These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2254041)

  • 1. Activity of type 1 erythrocyte complement receptors in uremia and after renal transplantation.
    Klinger M; Słowik E; Kopeć W; Szewczyk Z
    Int J Artif Organs; 1990 Oct; 13(10):658-62. PubMed ID: 2254041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of human erythrocyte C4d to erythrocyte complement receptor 1 ratio in cardiac transplant recipients with acute symptomatic allograft failure.
    Lee KC; Chang CY; Chuang YC; Sue SH; Chu TW; Chen RJ; Chen SH; Wei J; Chen CH
    Transplant Proc; 2008 Oct; 40(8):2638-42. PubMed ID: 18929826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of erythrocyte complement receptors class 1 in various kidney diseases].
    Klinger M; Słowik E; Kopeć W
    Pol Arch Med Wewn; 1991 Nov; 86(5):290-7. PubMed ID: 1821024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testicular function after renal transplantation: comparison of Cyclosporin A with azathioprine and prednisone combination regimes.
    Handelsman DJ; McDowell IF; Caterson ID; Tiller DJ; Hall BM; Turtle JR
    Clin Nephrol; 1984 Sep; 22(3):144-8. PubMed ID: 6386252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired loss of erythrocyte complement receptor type 1 in patients with diabetic nephropathy undergoing hemodialysis.
    Wakabayashi M; Ohi H; Tamano M; Onda K; Fujita T; Tomino Y
    Nephron Exp Nephrol; 2006; 104(3):e89-95. PubMed ID: 16837818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T lymphocytes in kidney allograft recipients.
    Tursz T; Fournier C; Kreis H; Crosnier J; Bach JF
    Br Med J; 1976 Apr; 1(6013):799-801. PubMed ID: 769903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extracorporeal irradiation of the blood. II. Immunosuppressive treatment in kidney transplantation].
    Weeke E; Andersen V; Sorensen SF; Bahr B
    Ugeskr Laeger; 1970 Mar; 132(12):580-5. PubMed ID: 4913225
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 9. [Erythrocyte CR1 receptor reactivity in patients with systemic lupus erythematosus].
    Said PB; Sarano J; Manni JA; Casellas AM
    Medicina (B Aires); 1990; 50(1):21-4. PubMed ID: 2149869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E; Robinson C; Bear R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of renal transplantation rejection. Cyclosporin A versus conventional treatment with azathioprine, prednisone and antithymocyte immunoglobulin in primary cadaveric renal transplantation.
    Hall BM; Tiller DJ; Horvath JS; Duggin GG; Johnson JR; Roy LP; Hurley B; Harris JP; Rogers JR; Stephen MS
    Med J Aust; 1985 Feb; 142(3):179-85. PubMed ID: 3881654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
    Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
    J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
    Yen JH; Liu HW; Lin SF; Chen JR; Chen TP
    J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
    Ng YC; Schifferli JA; Walport MJ
    Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphokine responses in renal transplant recipients.
    MacSween JM; Cohen AD; Rajaraman K; Fox RA
    Transplant Proc; 1982 Dec; 14(4):665-8. PubMed ID: 6762723
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of immunosuppressive problems in renal allograft recipients.
    Lorber MI; Flechner SM; Van Buren CT; Sorensen K; Kerman RH; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1951-4. PubMed ID: 3547899
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased frequency of posttransplant lymphomas in patients treated with cyclosporin, azathioprine, and prednisone.
    Smith JL; Wilkinson AH; Hunsicker LG; Tobacman J; Kapelanski DP; Johnson M; Wright FH; Behrendt DM; Corry RJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3199-200. PubMed ID: 2650451
    [No Abstract]   [Full Text] [Related]  

  • 18. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
    Pascual M; Schifferli JA
    Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic findings in acute renal allograft rejection with triple drug immunosuppressive therapy: a retrospective analysis.
    Moreno RF; Pallardo LM; Garcia J; Sanchez J; Rochera A; Cabezuelo J; de Agustin PP
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):5-6. PubMed ID: 3051590
    [No Abstract]   [Full Text] [Related]  

  • 20. [The kidney transplant].
    Montorsi W
    Minerva Med; 1974 Jan; 65(7):321-36. PubMed ID: 4595441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.